To stay globally competitive, the report recommended the U.S. increase tax incentives for research and development, cut corporate tax rates, provide more support for emerging fields, provide adequate resources for the FDA and the NIH, build human capital and expand the role of universities.
Related Articles on Medical Devices:
FDA, CMS Launch Pilot Program for Voluntary Review of Innovative Devices
Survey: Venture Capitalists Moving Away from Medical Device and Pharmaceutical Companies
FDA Forms Expert Panel to Speed up Device Approval
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.